Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00517322
Status:
UNKNOWN
Last Update Posted:
2007-08-16
First Post:
2007-08-15
Brief Title:
Left Atrial Remodelling in Hypertension Effects of Ramipril or Irbesartan
Sponsor:
Università degli Studi dellInsubria
Organization:
Università degli Studi dellInsubria
Study Overview
Official Title:
Left Atrial Remodelling in Hypertension Effects of Ramipril or Irbesartan
Status:
UNKNOWN
Status Verified Date:
2007-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aim of the study is to compare in hypertensive patients the effect of one year therapy with ACE-inhibitor RAMIPRIL or angiotensin II receptor blocker IRBESARTAN on left atrial remodelling and diastolic function
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None